KLACID

Medicinal product

(Invented) name

KLACID

Active substance (s)

Klaritromicinas

Strength

125 mg/5 ml

Pharmaceutical form

granulės geriamajai suspensijai

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

J01FA09, Clarithromycin

Marketing authorisation holder

UAB Lex ano, Lietuva

Date of authorisation

2025-12-10

Date of renewal

Documents

3064_KLACID 125 mg5 ml granulės geriamajai suspensijai_PL_2025-12-10.docx

3064_KLACID 125 mg5 ml granulės geriamajai suspensijai_PZ_2025-12-10.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

5 ml paruoštos geriamosios suspensijos yra:	5 ml
Klaritromicinas	125 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
119432	105536	1105536	buteliukas	100 ml ir geriamasis švirkštas, N1		Receptinis	LT/L/25/3064/001	Tiekiama	2026-02-02	-	No	-	-	Download

Stadijos

Data	Stadija
2025-12-10	Registruotas